Abstracts
tion increased their respective blood levels by 272% and 62% (p < 0.0001). Plasma cholesterol and triglycerides were normal and did not differ between groups. Despite this, EPA significantly reduced carotid endothelial protein expression of VCAM-1 and MCP-1 compared to no treatment (see table) . In the atherogenesis model, EPA and DHA increased their respective blood levels by 856% and 279% (p < 0.0001). Both EPA (-28%, p = 0.003) and DHA (-42%, p = 0.0001) reduced plasma triglycerides, and attenuated increases in cholesterol levels. However, this did not translate into favourable effects on plaque size, characteristics, or aortic lipid burden (see table) .
Conclusion: The omega-3 fatty acid EPA reduces acute vascular inflammation; however, neither EPA nor DHA favourably alters atherogenesis, plaque characteristics, or lipid burden. The effects of omega-3s on atherosclerosis and clinical outcomes warrant clinical validation.
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We aimed to assess the causes and outcomes of all out of hospital cardiac arrest (OOHCA) cases that were admitted to an inner city tertiary hospital over a two-year period and compare the data to published literature.
All OOHCA presentations to our Emergency Department (ED) from 1 Jan 2014 to 1 Jan 2016 were included. Patients that did not achieve return of spontaneous circulation (ROSC) and died in ED were not analysed further. We excluded arrests due to non-cardiac causes such as asphyxiation, drug overdose, trauma or intra-cerebral haemorrhage.
Patients who presented to ED with OOHCA were 16 to 98 years old, and 138 (69.0%) were male. ROSC was achieved in 76 (38.0%) patients and of these 39 (19.5%) subsequently died in hospital. In all 37 patients (18.5%) survived to discharge: of these 22 (59.5%) were discharged home, 11 (29.7%) to a rehabilitation facility and 4 (10.8%) to another hospital.
Of the 76 patients who achieved ROSC, 31 (40.8%) were still alive at one year; 15.5% of all OOHCA patients. 29 (38.2%) were due to coronary disease, 12 (15.8%) were due to cardiomyopathies, 3 (3.9%) were due to primary arrhythmias and 18 (23.7%) were idiopathic.
Patients who present to RPH with OOHCA have one-year survival rates comparable to national rates as quoted by the Australian Resuscitation Council (6-13%). As expected, the most common initial rhythm for patients surviving past ED was ventricular fibrillation. Survival post OOHCA was low and mortality was commonly within 1 week of presentation. 
